Multiple Sclerosis Drug Linked to Rare Brain Infection
Corey Allikas
The FDA is warning health care professionals about a rare brain infection seen in multiple sclerosis patients taking fingolimod (Gilenya).
Krystle Vermes
Baxter is recalling 1 lot of its 0.9% sodium chloride injection due to customer complaints of leaking containers, particulate matter, and missing port protectors, which could result in contamination.
Meghan Ross, Associate Editor
Plastic surgeons make better stitches when they listen to their favorite music, according to new research.
Ryan Marotta, Assistant Editor
The FDA has approved anticonvulsant levetiracetam (Spritam) for the treatment of seizures in adults and children with epilepsy.
Allison Gilchrist, Associate Editor
Patients are surfing the Internet to self-diagnose their symptoms more than ever.
Jeannette Y. Wick, RPh, MBA, FASCP
Current medication regimens used in bipolar I disorder produce suboptimal patient outcomes more often than not.
Krystle Vermes
Pharmacists should be aware that a clopidogrel tablet found in a bottle of hydrochlorothiazide tablets has prompted a product recall.
Meghan Ross, Associate Editor
A man wearing a ninja mask and carrying a martial-arts sword recently robbed a Walgreens pharmacy in California.

Association News

The newly updated White House strategy to combat HIV/AIDS includes principles that are at the heart of managed care pharmacy practices.
The American Pharmacists Association Foundation today announced Elizabeth K. Keyes, BSPharm, will serve as Interim Executive Director for APhA Foundation.
A new report from the Centers for Medicare and Medicaid Services finds that prescription drug spending increased 12.6 percent in 2014, the highest growth rate since 2002.
The American Pharmacists Association Foundation announces the honorees of the 2015 Pinnacle Awards.
The Biosimilars Council strongly urges the Department of Health and Human Services and the FDA to avoid any departure from the currently accepted international nonproprietary naming system.

Pharmacy Market News

Shire plc announced today that it has acquired New York-based, privately held Foresight Biotherapeutics Inc. for $300 million.
Teva Pharmaceutical Industries Ltd. and Immuneering Corporation announced that the companies have entered into an agreement in which Teva will purchase a 51% equity share of the company.

Strategic Alliance Partner News

CVS Health Corporation has announced operating results for the 3 months ended June 30, 2015.
CVS Health has entered into new clinical affiliations with two leading health care organizations, Lawrence Memorial Hospital in Kansas and Lehigh Valley Health Network in Pennsylvania.
Latest Issues